Dr Reddy’s Laboratories Rs18.5 billion acquisition of Wockhardt's assets

25/2/2020

Asset acquisition

Value:

Re 18.5 billion

Dollar value:

$ 259 million

Status:

Announced

Date:

25/2/2020

Overview:

Multinational pharmaceutical company Dr Reddy’s Laboratories is set to acquire 62 products and a manufacturing facility from pharmaceutical and biotechnology company Wockhardt for Rs18.5 billion in a slump sale.

Shah Shameer Ahmed - Researcher

Jurisdiction:

India

Deal type:

Asset acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences

Firm:

Cyril Amarchand Mangaldas

Party: Wockhardt (Seller)

Lawyers: Gautam Gandotra, Ramgovind Kuruppath

Related deals